Details for New Drug Application (NDA): 071798
✉ Email this page to a colleague
NDA 071798 describes TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES, which is a drug marketed by Kv Pharm and Cenci and is included in three NDAs. Additional details are available on the TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES profile page.
The generic ingredient in TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES is codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride. There are nineteen drug master file entries for this compound. Additional details are available on the codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride profile page.
The generic ingredient in TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES is codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride. There are nineteen drug master file entries for this compound. Additional details are available on the codeine phosphate; pseudoephedrine hydrochloride; triprolidine hydrochloride profile page.
Summary for 071798
| Tradename: | TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES |
| Applicant: | Kv Pharm |
| Ingredient: | pseudoephedrine hydrochloride; triprolidine hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 120MG;5MG | ||||
| Approval Date: | Mar 16, 1989 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
